Health AI in 2026: Exploring What’s Possible and What It Will Take to Get There

Pressure is visible across many healthcare systems today, including Portugal’s. Emergency departments close temporarily due to lack of staff, ambulance delays become more frequent and waiting times for medical appointments continue to increase. Inside hospitals and clinics, doctors, nurses, and other healthcare professionals work under constant strain, juggling clinical work with administrative demands. This is the context in which conversations about Artificial Intelligence in healthcare are taking place. Not as innovation for its own sake, but as a response to a system struggling to meet expectations with existing tools and structures. And what once felt hypothetical and experimental is now increasingly tangible and real.

Across care delivery, hospital operations, biomedical research, and patient engagement, AI is opening new ways to manage growing demand and complexity, extract insights from data, and support healthcare professionals and patients. In 2026, the conversation is less about if AI will shape healthcare, and more about how that transformation will unfold and what conditions are needed for it to scale.

Emerging uses of AI across healthcare

When discussing Health AI, it helps to distinguish between tools that primarily impact logistics and administration and those that begin to influence clinical decisions.

The first group improves processes that already exist without changing the treatment of the patient itself. These applications focus on areas such as scheduling, documentation, patient flow, staffing, billing, and operational planning. Because they optimize existing workflows rather than redefining care, they are usually easier to introduce and scale, and they often deliver quick gains in efficiency and professional satisfaction.

The second group is more disruptive. These are AI systems that support or inform clinical reasoning, such as tools for triage, risk stratification, exam interpretation, early detection of disease, and treatment planning. Their potential impact is greater, but so is their complexity. Unlike administrative systems, they interact directly with medical judgment and patient outcomes. That means they must be carefully validated, transparently designed, and embedded into clinical practice in a way that supports, rather than replaces, professional responsibility.

This distinction matters because it reflects different levels of risk and responsibility, and therefore different requirements for scale. Much of the public discourse around Health AI focuses on clinical breakthroughs, but in practice, the majority of deployed value today comes from systems that support the functioning of healthcare rather than redefining medical decisions.

Across both categories, the direction of progress is away from isolated tools and toward integrated digital support throughout the patient journey, with digital assistants embedded in healthcare services. These assistants can help patients navigate the system, book appointments, receive reminders, understand laboratory and imaging results, flag anomalies for clinical review, and coordinate follow-up care. When connected across systems, they improve continuity of care while reducing the administrative load placed on clinicians.

AI-enabled tools are also supporting a shift toward more proactive and personalized healthcare. Digital companions can help individuals monitor lifestyle factors, support adherence to treatment plans, track symptoms over time, and surface early warning signs before conditions escalate into acute episodes.

On the clinician side, one of the fastest-growing areas is ambient voice technology and AI-powered medical scribes. By automatically capturing and structuring clinical conversations, these systems reduce documentation time, allowing clinicians to be more present with patients and helping to mitigate burnout across healthcare systems. At the same time, clinical decision support systems can analyse multiple variables simultaneously, identifying relevant patterns and risks. When used responsibly, they reduce cognitive load and help minimize avoidable errors, while leaving the final decision firmly in human hands.

Taken together, these examples suggest that the future impact of Health AI will not come from individual applications deployed in isolation, but from the coordinated use of multiple tools embedded across care delivery and research ecosystems.

What it takes for AI to scale

The growing range of AI applications contrasts sharply with the difficulty of translating pilots into system-wide impact. This gap highlights the reality that translating AI’s potential into widespread and reliable impact depends on the underlying digital and data infrastructure, rather than just algorithm sophistication.

AI systems rely on high-quality, accessible, and interoperable data. In healthcare, that requires consistent digitization, standardized data models, and secure data flows across institutions and systems. Without these foundations, even the most advanced AI solutions struggle to move beyond pilots.

In Portugal, as in many other countries, healthcare information systems were designed to meet operational needs at a time when large-scale data reuse and AI were not primary considerations. Different institutions often run different versions of these systems, with different configurations and non-uniform health indicators, making data comparison and aggregation challenging.

Clinical data is distributed across multiple platforms, each designed for specific functions. Administrative information, clinical documentation, imaging, laboratory results, and specialty data often exist in separate systems, with varying degrees of interoperability.

This fragmentation has consequences. Data that cannot be easily combined or compared cannot reliably support analytics, learning, or AI. Gaps in interoperability translate into blind spots in system-wide understanding, duplicated work for professionals, and missed opportunities to improve care.

Portugal’s creation of SPMS was, in part, a response to this challenge. Its mandate to modernize digital health, and promote interoperability, reflects an understanding that digital infrastructure is necessary for efficiency, but also innovation.

Still, digitization is not simply a technical exercise. It is not about replacing paper with screens, but about redesigning how information is created, structured, and reused across the patient journey. When clinical information is captured primarily as free text, scanned documents, or disconnected records, it becomes difficult to learn from it at scale.

Digitization also requires moving beyond isolated systems. Today, many healthcare professionals navigate multiple platforms to access notes, results, and images, often re-entering the same information several times. This increases the risk of error and consumes time that could be spent on care.

Additionally, as data becomes more accessible, issues of security, privacy, and trust become central. Health data is among the most sensitive forms of information, and AI cannot be layered onto infrastructure that lacks clear governance. It is, therefore necessary to define who can access which data, for what purposes, and under what conditions for safe and sustainable use.

But digitization is also an organisational and cultural process. Technologies that do not fit naturally into workflows tend to generate workarounds that fragment data further. Preparing healthcare for AI therefore also means investing in training, redesigning processes, and ensuring that digital systems support professional practice rather than complicate it.

From this perspective, AI adoption is more than developing and deploying complex new algorithms and but about continuing to evolve shared national infrastructure so that data can flow safely, consistently, and meaningfully. Otherwise, we risk the technology remaining impressive in pilots but limited in impact and scale.

Placing Portugal in the European context

At the European level, these same challenges are being addressed through initiatives such as the European Health Data Space (EHDS). EHDS aims to standardize electronic health records, enable secure cross-border data exchange, and support the secondary use of health data for research, innovation, and AI development. In effect, it formalizes at a European scale the principles required nationally: interoperability, governance, and trusted data reuse.

Portugal’s national efforts align with this direction. Building on the foundations established through SPMS, the country has articulated a vision for Artificial Intelligence in Health that emphasizes interoperability, ethics, governance, and workforce readiness. Early AI and analytics pilots demonstrate progress, but they also underscore that isolated successes are not enough.

Responsible AI adoption in healthcare depends on the existence of a national interoperability infrastructure aligned with European standards, rather than on isolated technical upgrades. Achieving this will depend on sustained collaboration between government bodies, healthcare providers, technology partners, and academia.

A different way to think about Health AI in 2026

Viewed this way, the most meaningful Health AI trend for 2026 may not be a specific application, but the work of establishing the foundations required for safe, efficient, and high-quality AI.

The real opportunity lies in preparing healthcare systems to absorb AI responsibly and at scale through investment in digital infrastructure, data standardization, governance, and people. These efforts may attract less attention than AI-powered diagnostics or digital assistants, but they determine whether innovation becomes systemic or remains fragmented.

The impact of Health AI will be determined by healthcare system readiness as much as by advances in the technology itself. If the right foundations are put in place, the many promising applications already emerging can evolve from isolated examples into a sustainable, nation and Europe-wide reality.